• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessing the reproducibility of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer.评估乳腺癌小鼠模型中动态对比增强磁共振成像的可重复性。
Magn Reson Med. 2013 Jun;69(6):1721-34. doi: 10.1002/mrm.24422. Epub 2012 Jul 27.
2
Dynamic contrast-enhanced magnetic resonance imaging assessment of kidney function and renal masses: single slice versus whole organ/tumor.肾功能及肾肿块的动态对比增强磁共振成像评估:单层与全器官/肿瘤对比
Invest Radiol. 2014 Nov;49(11):720-7. doi: 10.1097/RLI.0000000000000075.
3
Repeatability of a reference region model for analysis of murine DCE-MRI data at 7T.用于分析7T小鼠动态对比增强磁共振成像(DCE-MRI)数据的参考区域模型的可重复性
J Magn Reson Imaging. 2006 Nov;24(5):1140-7. doi: 10.1002/jmri.20729.
4
Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.实性胰腺病变:应用时间-密度曲线动态对比增强磁共振成像评估的特征--初步研究。
Radiology. 2013 Jan;266(1):185-96. doi: 10.1148/radiol.12120111. Epub 2012 Nov 28.
5
The effects of intravoxel contrast agent diffusion on the analysis of DCE-MRI data in realistic tissue domains.在实际组织域中,对比剂扩散的体素内对比对 DCE-MRI 数据分析的影响。
Magn Reson Med. 2018 Jul;80(1):330-340. doi: 10.1002/mrm.26995. Epub 2017 Nov 8.
6
Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.肿瘤组织学与基于动态对比增强磁共振成像的生理学评估的比较。
Magn Reson Imaging. 2008 Nov;26(9):1279-93. doi: 10.1016/j.mri.2008.02.015. Epub 2008 May 19.
7
Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.3T磁共振成像动态对比增强扫描在前列腺癌中的应用:药代动力学参数研究
AJR Am J Roentgenol. 2007 Oct;189(4):849. doi: 10.2214/AJR.06.1329.
8
Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.利用动态对比增强磁共振成像的药代动力学参数评估肝纤维化
J Magn Reson Imaging. 2016 Jul;44(1):98-104. doi: 10.1002/jmri.25132. Epub 2015 Dec 28.
9
Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.前列腺优化快速动态对比增强磁共振成像:采样持续时间对药代动力学参数的影响
Invest Radiol. 2016 Feb;51(2):106-12. doi: 10.1097/RLI.0000000000000213.
10
A comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced MRI: application in carcinoma of the cervix.基于 T1 加权动态对比增强 MRI 的示踪剂动力学模型比较:在宫颈癌中的应用。
Magn Reson Med. 2010 Mar;63(3):691-700. doi: 10.1002/mrm.22217.

引用本文的文献

1
Structural and practical identifiability of contrast transport models for DCE-MRI.对比剂增强磁共振成像(DCE-MRI)对比传输模型的结构和实用可识别性。
PLoS Comput Biol. 2024 May 15;20(5):e1012106. doi: 10.1371/journal.pcbi.1012106. eCollection 2024 May.
2
Mathematical modelling of the dynamics of image-informed tumor habitats in a murine model of glioma.基于脑胶质瘤荷瘤鼠模型的影像引导肿瘤微环境动力学的数学建模。
Sci Rep. 2023 Feb 20;13(1):2916. doi: 10.1038/s41598-023-30010-6.
3
Repeatability of tumor perfusion kinetics from dynamic contrast-enhanced MRI in glioblastoma.胶质母细胞瘤动态对比增强磁共振成像中肿瘤灌注动力学的可重复性
Neurooncol Adv. 2021 Nov 22;3(1):vdab174. doi: 10.1093/noajnl/vdab174. eCollection 2021 Jan-Dec.
4
Biologically-Based Mathematical Modeling of Tumor Vasculature and Angiogenesis via Time-Resolved Imaging Data.通过时间分辨成像数据对肿瘤血管生成和血管新生进行基于生物学的数学建模。
Cancers (Basel). 2021 Jun 16;13(12):3008. doi: 10.3390/cancers13123008.
5
Multimodal Molecular Imaging Detects Early Responses to Immune Checkpoint Blockade.多模态分子成像检测免疫检查点阻断的早期反应。
Cancer Res. 2021 Jul 1;81(13):3693-3705. doi: 10.1158/0008-5472.CAN-20-3182. Epub 2021 Apr 9.
6
Co-Clinical Imaging Resource Program (CIRP): Bridging the Translational Divide to Advance Precision Medicine.联合临床影像资源计划(CIRP):弥合转化鸿沟,推进精准医学。
Tomography. 2020 Sep;6(3):273-287. doi: 10.18383/j.tom.2020.00023.
7
Selection of Fitting Model and Arterial Input Function for Repeatability in Dynamic Contrast-Enhanced Prostate MRI.动态对比增强前列腺 MRI 重复性的拟合模型和动脉输入函数选择。
Acad Radiol. 2019 Sep;26(9):e241-e251. doi: 10.1016/j.acra.2018.10.018. Epub 2018 Nov 20.
8
Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2+ breast cancer: preliminary results.曲妥珠单抗改善HER2阳性乳腺癌小鼠模型中肿瘤灌注及细胞毒性治疗的血管递送:初步结果
Breast Cancer Res Treat. 2016 Jan;155(2):273-84. doi: 10.1007/s10549-016-3680-8. Epub 2016 Jan 20.
9
MR Imaging Biomarkers in Oncology Clinical Trials.肿瘤学临床试验中的磁共振成像生物标志物
Magn Reson Imaging Clin N Am. 2016 Feb;24(1):11-29. doi: 10.1016/j.mric.2015.08.002.
10
Acute vascular response to cediranib treatment in human non-small-cell lung cancer xenografts with different tumour stromal architecture.西地尼布治疗对具有不同肿瘤基质结构的人非小细胞肺癌异种移植瘤的急性血管反应。
Lung Cancer. 2015 Nov;90(2):191-8. doi: 10.1016/j.lungcan.2015.08.009. Epub 2015 Aug 20.

本文引用的文献

1
Comparisons of the efficacy of a Jak1/2 inhibitor (AZD1480) with a VEGF signaling inhibitor (cediranib) and sham treatments in mouse tumors using DCE-MRI, DW-MRI, and histology.使用 DCE-MRI、DW-MRI 和组织学比较 Jak1/2 抑制剂 (AZD1480)、VEGF 信号抑制剂 (cediranib) 与假手术处理在小鼠肿瘤中的疗效。
Neoplasia. 2012 Jan;14(1):54-64. doi: 10.1593/neo.111478.
2
Statistical comparison of dynamic contrast-enhanced MRI pharmacokinetic models in human breast cancer.统计比较人类乳腺癌动态对比增强 MRI 药代动力学模型。
Magn Reson Med. 2012 Jul;68(1):261-71. doi: 10.1002/mrm.23205. Epub 2011 Nov 29.
3
Comparison of two vascular-disrupting agents at a clinically relevant dose in rodent liver tumors with multiparametric magnetic resonance imaging biomarkers.比较两种临床相关剂量的血管破坏剂在伴有多参数磁共振成像生物标志物的啮齿类肝脏肿瘤中的作用。
Anticancer Drugs. 2012 Jan;23(1):12-21. doi: 10.1097/CAD.0b013e328349dd60.
4
A quantitative comparison of the influence of individual versus population-derived vascular input functions on dynamic contrast enhanced-MRI in small animals.个体与群体来源血管输入函数对小动物动态对比增强 MRI 的影响的定量比较。
Magn Reson Med. 2012 Jan;67(1):226-36. doi: 10.1002/mrm.22988. Epub 2011 Jun 17.
5
Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects.评估多参数 MRI 在人类脑胶质瘤模型中对细胞毒性和抗血管生成药物作用的监测效果。
NMR Biomed. 2011 Jun;24(5):473-82. doi: 10.1002/nbm.1611. Epub 2010 Dec 8.
6
DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6.DCE-MRI 肿瘤异质性标志物可预测贝伐珠单抗联合 FOLFOX-6 治疗后 CRC 肝转移的退缩。
Br J Cancer. 2011 Jun 28;105(1):139-45. doi: 10.1038/bjc.2011.191. Epub 2011 Jun 14.
7
Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.应用动态对比增强磁共振成像预测接受新辅助化疗的原发性乳腺癌患者的生存情况。
Radiology. 2011 Jul;260(1):68-78. doi: 10.1148/radiol.11102493. Epub 2011 Apr 18.
8
PET imaging of early response to the tyrosine kinase inhibitor ZD4190.正电子发射断层扫描成像对酪氨酸激酶抑制剂 ZD4190 的早期反应评估。
Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1237-47. doi: 10.1007/s00259-011-1742-z. Epub 2011 Mar 1.
9
Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib.评价接受索拉非尼治疗的晚期非小细胞肺癌患者的 KRAS 突变、血管生成生物标志物和 DCE-MRI。
Clin Cancer Res. 2011 Mar 1;17(5):1190-9. doi: 10.1158/1078-0432.CCR-10-2331. Epub 2011 Jan 11.
10
Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples.肿瘤学中的动态对比增强磁共振成像:理论、数据采集、分析及实例
Curr Med Imaging Rev. 2009 May 1;3(2):91-107. doi: 10.2174/157340507780619179.

评估乳腺癌小鼠模型中动态对比增强磁共振成像的可重复性。

Assessing the reproducibility of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer.

机构信息

Institute of Imaging Science, Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, Tennessee 37232-2675, USA.

出版信息

Magn Reson Med. 2013 Jun;69(6):1721-34. doi: 10.1002/mrm.24422. Epub 2012 Jul 27.

DOI:10.1002/mrm.24422
PMID:22847762
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3740769/
Abstract

Quantitative dynamic contrast enhanced magnetic resonance imaging estimates parameters related to tissue vascularity and volume fractions; additionally, semiquantitative parameters such as the initial area under the curve can be utilized to describe tissue behavior. The aim of this study was to establish the reproducibility of quantitative and semiquantitative analysis of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer. For each animal, a T1-weighted, gradient-echo sequence was used to acquire two sets of dynamic contrast enhanced magnetic resonance imaging data separated by 5 h. Data were acquired at both a 0.05 mm3 (128(2) , n=12) and a 0.2 mm3 (64(2), n=12) resolution, and analysis was performed using both the Tofts-Kety (to estimate Ktrans and ve) and extended Tofts-Kety (Ktrans, ve, and vp) models. Reproducibility analysis was performed for both the center slice and the total tumor volume for all parameters. For the total volume analysis, the repeatability index for Ktrans is 0.073 min(-1) in the standard model analysis and 0.075 min(-1) in the extended model analysis at the 128(2) acquisition. For the 64(2) acquisition, the values are 0.089 and 0.063 min(-1) for the standard and extended models, respectively. The repeatability index for initial area under the curve was 0.0039 and 0.0042 mM min for the 128(2) and 64(2) acquisitions, respectively.

摘要

定量动态对比增强磁共振成像估计与组织血管生成和体积分数相关的参数;此外,还可以利用半定量参数,如初始曲线下面积来描述组织行为。本研究旨在建立乳腺癌小鼠模型中定量和半定量动态对比增强磁共振成像分析的可重复性。对于每只动物,使用 T1 加权梯度回波序列采集两组间隔 5 小时的动态对比增强磁共振成像数据。在 0.05mm3(128(2),n=12)和 0.2mm3(64(2),n=12)分辨率下采集数据,并使用 Tofts-Kety(估计 Ktrans 和 ve)和扩展 Tofts-Kety(Ktrans、ve 和 vp)模型进行分析。对所有参数的中心切片和整个肿瘤体积进行了重复性分析。对于全容积分析,在标准模型分析中 Ktrans 的重复性指数在 128(2)采集时为 0.073 min(-1),在扩展模型分析中为 0.075 min(-1)。对于 64(2)采集,标准和扩展模型的数值分别为 0.089 和 0.063 min(-1)。初始曲线下面积的重复性指数在 128(2)采集时为 0.0039,在 64(2)采集时为 0.0042 mM min。